BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18236294)

  • 1. Smoking cessation pharmacotherapy preferences in rural primary care.
    Cupertino PA; Richter KP; Cox LS; Nazir N; Greiner AK; Ahluwalia JS; Ellerbeck EF
    Nicotine Tob Res; 2008 Feb; 10(2):301-7. PubMed ID: 18236294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials.
    Lerman C; Jepson C; Wileyto EP; Epstein LH; Rukstalis M; Patterson F; Kaufmann V; Restine S; Hawk L; Niaura R; Berrettini W
    Neuropsychopharmacology; 2006 Jan; 31(1):231-42. PubMed ID: 16123753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Cancer: Smoking Cessation.
    Latimer KM
    FP Essent; 2018 Jan; 464():11-16. PubMed ID: 29313652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
    Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
    Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of tobacco dependence.
    Talwar A; Jain M; Vijayan VK
    Med Clin North Am; 2004 Nov; 88(6):1517-34. PubMed ID: 15464111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bupropion for smoking cessation: a review.
    Tong EK; Carmody TP; Simon JA
    Compr Ther; 2006; 32(1):26-33. PubMed ID: 16785579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacotherapy of smoking cessation.
    Peters MJ; Morgan LC
    Med J Aust; 2002 May; 176(10):486-90. PubMed ID: 12065013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latinos report less use of pharmaceutical aids when trying to quit smoking.
    Levinson AH; Pérez-Stable EJ; Espinoza P; Flores ET; Byers TE
    Am J Prev Med; 2004 Feb; 26(2):105-11. PubMed ID: 14751320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.
    Evins AE; Culhane MA; Alpert JE; Pava J; Liese BS; Farabaugh A; Fava M
    J Clin Psychopharmacol; 2008 Dec; 28(6):660-6. PubMed ID: 19011435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should all smokers use combination smoking cessation pharmacotherapy? Using novel analytic methods to detect differential treatment effects over 8 weeks of pharmacotherapy.
    Loh WY; Piper ME; Schlam TR; Fiore MC; Smith SS; Jorenby DE; Cook JW; Bolt DM; Baker TB
    Nicotine Tob Res; 2012 Feb; 14(2):131-41. PubMed ID: 22180577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion for smoking cessation: a randomized trial.
    Simon JA; Duncan C; Carmody TP; Hudes ES
    Arch Intern Med; 2004 Sep; 164(16):1797-803. PubMed ID: 15364675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of varying levels of disease management on smoking cessation: a randomized trial.
    Ellerbeck EF; Mahnken JD; Cupertino AP; Cox LS; Greiner KA; Mussulman LM; Nazir N; Shireman TI; Resnicow K; Ahluwalia JS
    Ann Intern Med; 2009 Apr; 150(7):437-46. PubMed ID: 19349629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation of pharmacotherapies for smoking cessation].
    Antoñanzas F; Portillo F
    Gac Sanit; 2003; 17(5):393-403. PubMed ID: 14599422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of bupropion in the management of smoking cessation.
    Jorenby D
    Drugs; 2002; 62 Suppl 2():25-35. PubMed ID: 12109933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of bupropion for smoking cessation.
    Richmond R; Zwar N
    Drug Alcohol Rev; 2003 Jun; 22(2):203-20. PubMed ID: 12850907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Varenicline: a first-line treatment option for smoking cessation.
    Garrison GD; Dugan SE
    Clin Ther; 2009 Mar; 31(3):463-91. PubMed ID: 19393839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
    Simon JA; Duncan C; Huggins J; Solkowitz S; Carmody TP
    Nicotine Tob Res; 2009 Jun; 11(6):663-9. PubMed ID: 19395688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current pharmacological treatments for nicotine dependence.
    George TP; O'Malley SS
    Trends Pharmacol Sci; 2004 Jan; 25(1):42-8. PubMed ID: 14723978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.